Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.

Maen AbdelrahimHadeel Al-RawiAbdullah EsmailJiaqiong XuGodsfavour UmoruFahad IbnshamsahAla AbudayyehDavid VictorAshish SahariaRobert McMillanEbtesam Al NajjarDoaa BugaziaMaryam Al-RawiRafik M Ghobrial

Published in: Current oncology (Toronto, Ont.) (2022)

Our finding demonstrated that neo-adjuvant gemcitabine and cisplatin with no radiation prior to liver transplantation resulted in excellent outcomes for patients with cholangiocarcinoma.

Keyphrases

end stage renal disease
early stage
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
locally advanced
type diabetes
radiation therapy
metabolic syndrome